Rank | Gene Set | Z-score |
---|---|---|
1 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.46760728 |
2 | L-phenylalanine catabolic process (GO:0006559) | 6.46760728 |
3 | L-phenylalanine metabolic process (GO:0006558) | 6.26032419 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 6.26032419 |
5 | aromatic amino acid family catabolic process (GO:0009074) | 5.80145647 |
6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.78588818 |
7 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.54937562 |
8 | kynurenine metabolic process (GO:0070189) | 5.41013954 |
9 | urea metabolic process (GO:0019627) | 5.38616836 |
10 | urea cycle (GO:0000050) | 5.38616836 |
11 | bile acid biosynthetic process (GO:0006699) | 5.30197479 |
12 | indole-containing compound catabolic process (GO:0042436) | 5.23862256 |
13 | indolalkylamine catabolic process (GO:0046218) | 5.23862256 |
14 | tryptophan catabolic process (GO:0006569) | 5.23862256 |
15 | negative regulation of fibrinolysis (GO:0051918) | 5.18080613 |
16 | sulfur amino acid catabolic process (GO:0000098) | 5.14345043 |
17 | glyoxylate metabolic process (GO:0046487) | 5.12675213 |
18 | cysteine metabolic process (GO:0006534) | 4.99362410 |
19 | tryptophan metabolic process (GO:0006568) | 4.99104422 |
20 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.97661891 |
21 | nitrogen cycle metabolic process (GO:0071941) | 4.96269969 |
22 | regulation of protein activation cascade (GO:2000257) | 4.95735856 |
23 | complement activation, alternative pathway (GO:0006957) | 4.90993219 |
24 | serine family amino acid catabolic process (GO:0009071) | 4.90074628 |
25 | protein carboxylation (GO:0018214) | 4.85241147 |
26 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.85241147 |
27 | high-density lipoprotein particle remodeling (GO:0034375) | 4.77725913 |
28 | regulation of fibrinolysis (GO:0051917) | 4.73287945 |
29 | regulation of complement activation (GO:0030449) | 4.68595095 |
30 | lysine catabolic process (GO:0006554) | 4.66062025 |
31 | lysine metabolic process (GO:0006553) | 4.66062025 |
32 | bile acid metabolic process (GO:0008206) | 4.59620862 |
33 | homocysteine metabolic process (GO:0050667) | 4.56311993 |
34 | amino-acid betaine metabolic process (GO:0006577) | 4.41054316 |
35 | negative regulation of sterol transport (GO:0032372) | 4.36210804 |
36 | negative regulation of cholesterol transport (GO:0032375) | 4.36210804 |
37 | reverse cholesterol transport (GO:0043691) | 4.34173438 |
38 | regulation of triglyceride catabolic process (GO:0010896) | 4.32365045 |
39 | regulation of cholesterol homeostasis (GO:2000188) | 4.26186162 |
40 | aromatic amino acid family metabolic process (GO:0009072) | 4.24558386 |
41 | plasma lipoprotein particle clearance (GO:0034381) | 4.20460701 |
42 | alpha-amino acid catabolic process (GO:1901606) | 4.17854633 |
43 | tyrosine metabolic process (GO:0006570) | 4.16859854 |
44 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.16009410 |
45 | regulation of cholesterol esterification (GO:0010872) | 4.10184735 |
46 | protein-lipid complex remodeling (GO:0034368) | 4.08523354 |
47 | macromolecular complex remodeling (GO:0034367) | 4.08523354 |
48 | plasma lipoprotein particle remodeling (GO:0034369) | 4.08523354 |
49 | protein localization to endosome (GO:0036010) | 4.06428333 |
50 | glycine metabolic process (GO:0006544) | 4.06011866 |
51 | triglyceride homeostasis (GO:0070328) | 4.05270142 |
52 | acylglycerol homeostasis (GO:0055090) | 4.05270142 |
53 | glutamate metabolic process (GO:0006536) | 4.01884426 |
54 | ethanol oxidation (GO:0006069) | 3.97580642 |
55 | phospholipid efflux (GO:0033700) | 3.97580132 |
56 | cellular modified amino acid catabolic process (GO:0042219) | 3.93858385 |
57 | cellular amino acid catabolic process (GO:0009063) | 3.90338564 |
58 | phospholipid homeostasis (GO:0055091) | 3.88101905 |
59 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.86979161 |
60 | coenzyme catabolic process (GO:0009109) | 3.85615492 |
61 | serine family amino acid metabolic process (GO:0009069) | 3.84899085 |
62 | bile acid and bile salt transport (GO:0015721) | 3.84764989 |
63 | cholesterol efflux (GO:0033344) | 3.80236928 |
64 | acetyl-CoA metabolic process (GO:0006084) | 3.77047826 |
65 | plasma lipoprotein particle assembly (GO:0034377) | 3.76072061 |
66 | positive regulation of lipid catabolic process (GO:0050996) | 3.73678474 |
67 | drug catabolic process (GO:0042737) | 3.70267328 |
68 | imidazole-containing compound metabolic process (GO:0052803) | 3.69405677 |
69 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.65881351 |
70 | indolalkylamine metabolic process (GO:0006586) | 3.61656886 |
71 | 2-oxoglutarate metabolic process (GO:0006103) | 3.61621801 |
72 | protein-lipid complex assembly (GO:0065005) | 3.59126158 |
73 | cellular glucuronidation (GO:0052695) | 3.58437787 |
74 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.58364955 |
75 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.58364955 |
76 | aspartate family amino acid catabolic process (GO:0009068) | 3.56894374 |
77 | benzene-containing compound metabolic process (GO:0042537) | 3.53586060 |
78 | cholesterol homeostasis (GO:0042632) | 3.50583805 |
79 | cellular ketone body metabolic process (GO:0046950) | 3.50105373 |
80 | serine family amino acid biosynthetic process (GO:0009070) | 3.49952442 |
81 | sterol homeostasis (GO:0055092) | 3.46461124 |
82 | barbed-end actin filament capping (GO:0051016) | 3.44566870 |
83 | arginine metabolic process (GO:0006525) | 3.43276432 |
84 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.40174293 |
85 | short-chain fatty acid metabolic process (GO:0046459) | 3.39217230 |
86 | cellular biogenic amine catabolic process (GO:0042402) | 3.38252003 |
87 | amine catabolic process (GO:0009310) | 3.38252003 |
88 | complement activation, classical pathway (GO:0006958) | 3.37568022 |
89 | heme transport (GO:0015886) | 3.37125937 |
90 | carboxylic acid catabolic process (GO:0046395) | 3.36291884 |
91 | organic acid catabolic process (GO:0016054) | 3.36291884 |
92 | epoxygenase P450 pathway (GO:0019373) | 3.34950365 |
93 | fibrinolysis (GO:0042730) | 3.34449879 |
94 | regulation of bile acid biosynthetic process (GO:0070857) | 3.34333822 |
95 | lipoprotein metabolic process (GO:0042157) | 3.33420865 |
96 | complement activation (GO:0006956) | 3.29476947 |
97 | valine metabolic process (GO:0006573) | 3.27196082 |
98 | low-density lipoprotein particle remodeling (GO:0034374) | 3.23729569 |
99 | cytolysis (GO:0019835) | 3.22929409 |
100 | plasma lipoprotein particle organization (GO:0071827) | 3.21649638 |
101 | exogenous drug catabolic process (GO:0042738) | 3.20404232 |
102 | negative regulation of lipase activity (GO:0060192) | 3.20180044 |
103 | stress fiber assembly (GO:0043149) | 3.03384043 |
104 | positive regulation by symbiont of host defense response (GO:0052509) | 2.98536243 |
105 | modulation by symbiont of host defense response (GO:0052031) | 2.98536243 |
106 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.98536243 |
107 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.98536243 |
108 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.98536243 |
109 | modulation by symbiont of host immune response (GO:0052553) | 2.98536243 |
110 | amino sugar catabolic process (GO:0046348) | 2.89192638 |
111 | negative regulation of retinoic acid receptor signaling pathway (GO:0048387) | 2.87172898 |
112 | autophagic vacuole assembly (GO:0000045) | 2.79786384 |
113 | response to muramyl dipeptide (GO:0032495) | 2.77125369 |
114 | amyloid precursor protein catabolic process (GO:0042987) | 2.67065715 |
115 | detection of molecule of bacterial origin (GO:0032490) | 2.66873254 |
116 | neutrophil activation involved in immune response (GO:0002283) | 2.66423143 |
117 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.66256608 |
118 | response to peptidoglycan (GO:0032494) | 2.66096135 |
119 | response to laminar fluid shear stress (GO:0034616) | 2.61846800 |
120 | Golgi transport vesicle coating (GO:0048200) | 2.60419601 |
121 | COPI coating of Golgi vesicle (GO:0048205) | 2.60419601 |
122 | regulation of early endosome to late endosome transport (GO:2000641) | 2.58729932 |
123 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.54474185 |
124 | skin morphogenesis (GO:0043589) | 2.52239098 |
125 | NIK/NF-kappaB signaling (GO:0038061) | 2.48895578 |
126 | macrophage activation involved in immune response (GO:0002281) | 2.48136153 |
127 | negative regulation of cell killing (GO:0031342) | 2.47321579 |
128 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.47321579 |
129 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.45578066 |
130 | regulation of ARF protein signal transduction (GO:0032012) | 2.44397589 |
131 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.43853486 |
132 | positive regulation of receptor recycling (GO:0001921) | 2.41917932 |
133 | cellular response to nerve growth factor stimulus (GO:1990090) | 2.37634569 |
134 | response to nerve growth factor (GO:1990089) | 2.37634569 |
135 | substrate-dependent cell migration (GO:0006929) | 2.35167252 |
136 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.32483921 |
137 | regulation of leukocyte degranulation (GO:0043300) | 2.31805826 |
138 | macroautophagy (GO:0016236) | 2.30795794 |
139 | positive regulation of cholesterol efflux (GO:0010875) | 2.29195807 |
140 | cellular response to arsenic-containing substance (GO:0071243) | 2.27662400 |
141 | negative regulation of interleukin-12 production (GO:0032695) | 2.26387871 |
142 | granulocyte activation (GO:0036230) | 2.26368060 |
143 | detection of other organism (GO:0098543) | 2.25915089 |
144 | regulation of retinoic acid receptor signaling pathway (GO:0048385) | 2.25233352 |
145 | signal complex assembly (GO:0007172) | 2.22273834 |
146 | viral protein processing (GO:0019082) | 2.21966410 |
147 | endocytic recycling (GO:0032456) | 2.21224040 |
148 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.20428394 |
149 | detection of external biotic stimulus (GO:0098581) | 2.19218173 |
150 | vacuole organization (GO:0007033) | 2.19142901 |
151 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.17279119 |
152 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.16318539 |
153 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.16085068 |
154 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.15910669 |
155 | positive regulation of fibroblast migration (GO:0010763) | 2.15216529 |
156 | low-density lipoprotein particle clearance (GO:0034383) | 2.14215872 |
157 | membrane invagination (GO:0010324) | 2.13448567 |
158 | cell adhesion mediated by integrin (GO:0033627) | 2.11892890 |
159 | germinal center formation (GO:0002467) | 2.11201767 |
160 | positive regulation of p38MAPK cascade (GO:1900745) | 2.09047888 |
161 | negative regulation of glial cell proliferation (GO:0060253) | 2.08394865 |
162 | regulation of mast cell degranulation (GO:0043304) | 2.07864003 |
163 | mannose metabolic process (GO:0006013) | 2.07042698 |
164 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.06994444 |
165 | hemoglobin metabolic process (GO:0020027) | 2.06238232 |
166 | protein targeting to plasma membrane (GO:0072661) | 2.06111318 |
167 | detection of bacterium (GO:0016045) | 2.05851721 |
168 | regulation of regulated secretory pathway (GO:1903305) | 2.05817840 |
169 | regulation of macrophage cytokine production (GO:0010935) | 2.03399490 |
170 | positive regulation of protein homooligomerization (GO:0032464) | 2.03034077 |
171 | semaphorin-plexin signaling pathway (GO:0071526) | 2.02298210 |
172 | nerve growth factor signaling pathway (GO:0038180) | 2.02173107 |
173 | neutrophil activation (GO:0042119) | 2.01826597 |
174 | positive regulation of leukocyte degranulation (GO:0043302) | 2.00733776 |
175 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.00537998 |
176 | mitochondrion degradation (GO:0000422) | 2.00226420 |
177 | hyaluronan catabolic process (GO:0030214) | 1.99885584 |
178 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 1.98787025 |
179 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 1.98031643 |
180 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 1.97979142 |
181 | negative regulation of glycoprotein metabolic process (GO:1903019) | 1.97938279 |
182 | negative regulation of glycoprotein biosynthetic process (GO:0010561) | 1.97875008 |
183 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 1.97573925 |
184 | negative regulation of protein localization to plasma membrane (GO:1903077) | 1.95565561 |
185 | protein retention in ER lumen (GO:0006621) | 1.94683186 |
186 | regulation of necroptotic process (GO:0060544) | 1.94344474 |
187 | receptor recycling (GO:0001881) | 1.93903475 |
188 | basement membrane organization (GO:0071711) | 1.93192971 |
189 | regulation of Rho protein signal transduction (GO:0035023) | 1.92509778 |
190 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 1.91768813 |
191 | amyloid precursor protein metabolic process (GO:0042982) | 1.91422735 |
192 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 1.91360234 |
193 | regulation of mast cell activation involved in immune response (GO:0033006) | 1.90832260 |
194 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 1.90791981 |
195 | activation of MAPKKK activity (GO:0000185) | 1.90747676 |
196 | fibril organization (GO:0097435) | 1.89339713 |
197 | regulation of cholesterol storage (GO:0010885) | 1.88587990 |
198 | peptide catabolic process (GO:0043171) | 1.88285754 |
199 | type B pancreatic cell proliferation (GO:0044342) | 1.87407323 |
200 | virion assembly (GO:0019068) | 1.87366425 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.66731160 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.99683670 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 6.15228906 |
4 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.63503651 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.85751196 |
6 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.37751449 |
7 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.22156731 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.76022664 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.29167415 |
10 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.69112301 |
11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.34643015 |
12 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.10513227 |
13 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.09888202 |
14 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.05386077 |
15 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.97598060 |
16 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.92309573 |
17 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.89463004 |
18 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.88933403 |
19 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.87272442 |
20 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.82537924 |
21 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.82315909 |
22 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.76092475 |
23 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.72914973 |
24 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.70996505 |
25 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.66615930 |
26 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.62304140 |
27 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.58959912 |
28 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.58357899 |
29 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.57969740 |
30 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.57202384 |
31 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.54755452 |
32 | * TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.53866635 |
33 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.48289418 |
34 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.47928147 |
35 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.46487378 |
36 | SPI1_23127762_ChIP-Seq_K562_Human | 1.43647726 |
37 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.43112160 |
38 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.42338123 |
39 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.41709458 |
40 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.40554102 |
41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.39958261 |
42 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38099841 |
43 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36072773 |
44 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.31062073 |
45 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.30689285 |
46 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.29199401 |
47 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.27492615 |
48 | * SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.26471630 |
49 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.26249265 |
50 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.25863086 |
51 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.24361397 |
52 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.23663980 |
53 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.22865060 |
54 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.21401453 |
55 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.21120434 |
56 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.20475847 |
57 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.18371711 |
58 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.17916367 |
59 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.17037677 |
60 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.16340530 |
61 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.16017499 |
62 | * RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.14453633 |
63 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.13892702 |
64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.13163217 |
65 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10810353 |
66 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.10218913 |
67 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.09997227 |
68 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.09421097 |
69 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.09368130 |
70 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.07564127 |
71 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.02901605 |
72 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.01847235 |
73 | MAF_26560356_Chip-Seq_TH1_Human | 1.01660661 |
74 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.01327027 |
75 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01185165 |
76 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00591963 |
77 | GATA1_22025678_ChIP-Seq_K562_Human | 1.00237164 |
78 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.99943016 |
79 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.99676901 |
80 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.99354379 |
81 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.98537140 |
82 | * TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.98390437 |
83 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.98308042 |
84 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98052506 |
85 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.97900906 |
86 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97161031 |
87 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.97140442 |
88 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.96758163 |
89 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.95341811 |
90 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.94617315 |
91 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.93734062 |
92 | MAF_26560356_Chip-Seq_TH2_Human | 0.93640847 |
93 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.93250322 |
94 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.92738939 |
95 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 0.91972292 |
96 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.90764551 |
97 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.90278256 |
98 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.90122834 |
99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.89961289 |
100 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.89552329 |
101 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.88945961 |
102 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.87323943 |
103 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.87215338 |
104 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.87211826 |
105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.86982942 |
106 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 0.86759053 |
107 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.86228050 |
108 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.85837839 |
109 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85143579 |
110 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.84375786 |
111 | KDM2B_26808549_Chip-Seq_K562_Human | 0.84360973 |
112 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.84039991 |
113 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.83975939 |
114 | GATA1_19941826_ChIP-Seq_K562_Human | 0.81815991 |
115 | GATA4_25053715_ChIP-Seq_YYC3_Human | 0.80384564 |
116 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.79982178 |
117 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.79477649 |
118 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.79023731 |
119 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78770933 |
120 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78674537 |
121 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.78593684 |
122 | * GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78504390 |
123 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.78343003 |
124 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.78068442 |
125 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77968293 |
126 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.77550130 |
127 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.77393894 |
128 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.76143041 |
129 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.76143041 |
130 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 0.75989710 |
131 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.75599573 |
132 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.74811660 |
133 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73287989 |
134 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.71723454 |
135 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.71610731 |
136 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.71535897 |
137 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.71508849 |
138 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 0.71151793 |
139 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.70768261 |
140 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70588062 |
141 | ATF3_27146783_Chip-Seq_COLON_Human | 0.70160170 |
142 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.67806806 |
143 | POU5F1_16518401_ChIP-PET_MESCs_Mouse | 0.65652679 |
144 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.65500153 |
145 | P68_20966046_ChIP-Seq_HELA_Human | 0.65364996 |
146 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.65293814 |
147 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.64078726 |
148 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.63322683 |
149 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.63098277 |
150 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.62500292 |
151 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.61797321 |
152 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.61121477 |
153 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.60642183 |
154 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.60572936 |
155 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.60033031 |
156 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.59720345 |
157 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.59154914 |
158 | TFAP2A_17053090_ChIP-ChIP_MCF-7_Human | 0.58046961 |
159 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.57970991 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.75216342 |
2 | MP0005360_urolithiasis | 7.10290567 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.92985579 |
4 | MP0005365_abnormal_bile_salt | 5.87302385 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.32114613 |
6 | MP0003252_abnormal_bile_duct | 3.95839139 |
7 | MP0003806_abnormal_nucleotide_metabolis | 3.68129248 |
8 | MP0009840_abnormal_foam_cell | 3.60835468 |
9 | MP0010329_abnormal_lipoprotein_level | 3.56598026 |
10 | MP0008260_abnormal_autophagy | 3.47218367 |
11 | MP0003303_peritoneal_inflammation | 3.39558221 |
12 | MP0005332_abnormal_amino_acid | 2.62378164 |
13 | MP0003705_abnormal_hypodermis_morpholog | 2.60239506 |
14 | MP0005083_abnormal_biliary_tract | 2.59535887 |
15 | MP0004510_myositis | 2.58918070 |
16 | MP0003724_increased_susceptibility_to | 2.39533477 |
17 | MP0001666_abnormal_nutrient_absorption | 2.34553809 |
18 | MP0003191_abnormal_cellular_cholesterol | 2.33479271 |
19 | MP0003436_decreased_susceptibility_to | 2.26620955 |
20 | MP0000609_abnormal_liver_physiology | 2.20374141 |
21 | MP0003279_aneurysm | 2.20111262 |
22 | MP0003195_calcinosis | 2.10481637 |
23 | MP0002118_abnormal_lipid_homeostasis | 2.08709509 |
24 | MP0004019_abnormal_vitamin_homeostasis | 1.98811754 |
25 | MP0002877_abnormal_melanocyte_morpholog | 1.86519345 |
26 | MP0000015_abnormal_ear_pigmentation | 1.85216090 |
27 | MP0004233_abnormal_muscle_weight | 1.84613864 |
28 | MP0000751_myopathy | 1.84099000 |
29 | MP0005319_abnormal_enzyme/_coenzyme | 1.80685581 |
30 | MP0001958_emphysema | 1.73045851 |
31 | MP0003091_abnormal_cell_migration | 1.68229882 |
32 | MP0003828_pulmonary_edema | 1.66792486 |
33 | MP0002138_abnormal_hepatobiliary_system | 1.62931716 |
34 | MP0005275_abnormal_skin_tensile | 1.62765388 |
35 | MP0003183_abnormal_peptide_metabolism | 1.62645658 |
36 | MP0005257_abnormal_intraocular_pressure | 1.59417926 |
37 | MP0009278_abnormal_bone_marrow | 1.52527107 |
38 | MP0003868_abnormal_feces_composition | 1.52069094 |
39 | MP0002332_abnormal_exercise_endurance | 1.50957230 |
40 | MP0006054_spinal_hemorrhage | 1.50497061 |
41 | MP0001533_abnormal_skeleton_physiology | 1.48077483 |
42 | MP0005670_abnormal_white_adipose | 1.47599392 |
43 | MP0002998_abnormal_bone_remodeling | 1.44220357 |
44 | MP0000604_amyloidosis | 1.43556224 |
45 | MP0002419_abnormal_innate_immunity | 1.41527056 |
46 | MP0000750_abnormal_muscle_regeneration | 1.38980627 |
47 | MP0000343_altered_response_to | 1.37413054 |
48 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.35719249 |
49 | MP0002254_reproductive_system_inflammat | 1.34796289 |
50 | MP0003221_abnormal_cardiomyocyte_apopto | 1.30831111 |
51 | MP0001542_abnormal_bone_strength | 1.27532671 |
52 | MP0009643_abnormal_urine_homeostasis | 1.24698757 |
53 | MP0004130_abnormal_muscle_cell | 1.24242466 |
54 | MP0006082_CNS_inflammation | 1.23750802 |
55 | MP0000598_abnormal_liver_morphology | 1.21470064 |
56 | MP0005464_abnormal_platelet_physiology | 1.17504299 |
57 | MP0002148_abnormal_hypersensitivity_rea | 1.17013722 |
58 | MP0003656_abnormal_erythrocyte_physiolo | 1.16161201 |
59 | MP0004947_skin_inflammation | 1.14202734 |
60 | MP0000759_abnormal_skeletal_muscle | 1.13007047 |
61 | MP0005397_hematopoietic_system_phenotyp | 1.12924409 |
62 | MP0001545_abnormal_hematopoietic_system | 1.12924409 |
63 | MP0000920_abnormal_myelination | 1.12791351 |
64 | MP0001764_abnormal_homeostasis | 1.10963732 |
65 | MP0005025_abnormal_response_to | 1.10558791 |
66 | MP0003329_amyloid_beta_deposits | 1.10024985 |
67 | MP0005451_abnormal_body_composition | 1.08355233 |
68 | MP0000733_abnormal_muscle_development | 1.08251862 |
69 | MP0005171_absent_coat_pigmentation | 1.07074854 |
70 | MP0009785_altered_susceptibility_to | 1.06224546 |
71 | MP0004272_abnormal_basement_membrane | 1.06091255 |
72 | MP0000767_abnormal_smooth_muscle | 1.05264730 |
73 | MP0004381_abnormal_hair_follicle | 1.04449531 |
74 | MP0005647_abnormal_sex_gland | 1.03759287 |
75 | MP0002295_abnormal_pulmonary_circulatio | 1.01916424 |
76 | MP0005000_abnormal_immune_tolerance | 1.01563021 |
77 | MP0005666_abnormal_adipose_tissue | 1.01328604 |
78 | MP0000749_muscle_degeneration | 0.99807381 |
79 | MP0005390_skeleton_phenotype | 0.98573853 |
80 | MP0008004_abnormal_stomach_pH | 0.96900516 |
81 | MP0005058_abnormal_lysosome_morphology | 0.92625605 |
82 | MP0005409_darkened_coat_color | 0.92152317 |
83 | MP0003690_abnormal_glial_cell | 0.92061739 |
84 | MP0001986_abnormal_taste_sensitivity | 0.87760066 |
85 | MP0002971_abnormal_brown_adipose | 0.85169001 |
86 | MP0000858_altered_metastatic_potential | 0.84716692 |
87 | MP0009053_abnormal_anal_canal | 0.82581245 |
88 | MP0002896_abnormal_bone_mineralization | 0.82410270 |
89 | MP0008438_abnormal_cutaneous_collagen | 0.82076791 |
90 | MP0003634_abnormal_glial_cell | 0.82039330 |
91 | MP0003011_delayed_dark_adaptation | 0.81630770 |
92 | MP0001661_extended_life_span | 0.81260992 |
93 | MP0003300_gastrointestinal_ulcer | 0.80504058 |
94 | MP0004185_abnormal_adipocyte_glucose | 0.80470797 |
95 | MP0001756_abnormal_urination | 0.79709359 |
96 | MP0002078_abnormal_glucose_homeostasis | 0.79411415 |
97 | MP0005503_abnormal_tendon_morphology | 0.79202304 |
98 | MP0009763_increased_sensitivity_to | 0.79030576 |
99 | MP0010234_abnormal_vibrissa_follicle | 0.79018955 |
100 | MP0001790_abnormal_immune_system | 0.78201996 |
101 | MP0005387_immune_system_phenotype | 0.78201996 |
102 | MP0004859_abnormal_synaptic_plasticity | 0.77008949 |
103 | MP0003186_abnormal_redox_activity | 0.76409460 |
104 | MP0009642_abnormal_blood_homeostasis | 0.76095482 |
105 | MP0003879_abnormal_hair_cell | 0.76006877 |
106 | MP0008961_abnormal_basal_metabolism | 0.74967051 |
107 | MP0009764_decreased_sensitivity_to | 0.74709324 |
108 | MP0002060_abnormal_skin_morphology | 0.74414474 |
109 | MP0005334_abnormal_fat_pad | 0.73466674 |
110 | MP0002269_muscular_atrophy | 0.72610571 |
111 | MP0005508_abnormal_skeleton_morphology | 0.69928415 |
112 | MP0005164_abnormal_response_to | 0.69926502 |
113 | MP0009697_abnormal_copulation | 0.69757723 |
114 | MP0003448_altered_tumor_morphology | 0.69639848 |
115 | MP0001835_abnormal_antigen_presentation | 0.69414821 |
116 | MP0009333_abnormal_splenocyte_physiolog | 0.68486249 |
117 | MP0004087_abnormal_muscle_fiber | 0.68398960 |
118 | MP0002452_abnormal_antigen_presenting | 0.68081455 |
119 | MP0000685_abnormal_immune_system | 0.67489604 |
120 | MP0010386_abnormal_urinary_bladder | 0.67399765 |
121 | MP0005621_abnormal_cell_physiology | 0.67152323 |
122 | MP0003795_abnormal_bone_structure | 0.66915783 |
123 | MP0005636_abnormal_mineral_homeostasis | 0.66777197 |
124 | MP0009765_abnormal_xenobiotic_induced | 0.65270461 |
125 | MP0005410_abnormal_fertilization | 0.65224765 |
126 | MP0003566_abnormal_cell_adhesion | 0.61813007 |
127 | MP0008469_abnormal_protein_level | 0.59548155 |
128 | MP0005248_abnormal_Harderian_gland | 0.59266151 |
129 | MP0002168_other_aberrant_phenotype | 0.58507821 |
130 | MP0005408_hypopigmentation | 0.58162410 |
131 | MP0004858_abnormal_nervous_system | 0.58161434 |
132 | MP0004264_abnormal_extraembryonic_tissu | 0.58147809 |
133 | MP0005376_homeostasis/metabolism_phenot | 0.58048337 |
134 | MP0005375_adipose_tissue_phenotype | 0.57738962 |
135 | MP0009672_abnormal_birth_weight | 0.57379239 |
136 | MP0005023_abnormal_wound_healing | 0.55990125 |
137 | MP0005266_abnormal_metabolism | 0.55929213 |
138 | MP0001849_ear_inflammation | 0.55560092 |
139 | MP0005535_abnormal_body_temperature | 0.55228134 |
140 | MP0003172_abnormal_lysosome_physiology | 0.55127615 |
141 | MP0005448_abnormal_energy_balance | 0.53963785 |
142 | MP0001915_intracranial_hemorrhage | 0.53758134 |
143 | MP0002136_abnormal_kidney_physiology | 0.52602613 |
144 | MP0000639_abnormal_adrenal_gland | 0.52125531 |
145 | MP0009115_abnormal_fat_cell | 0.51545016 |
146 | MP0002928_abnormal_bile_duct | 0.48914585 |
147 | MP0010368_abnormal_lymphatic_system | 0.48859653 |
148 | MP0008874_decreased_physiological_sensi | 0.47212558 |
149 | MP0005076_abnormal_cell_differentiation | 0.46458477 |
150 | MP0005167_abnormal_blood-brain_barrier | 0.45817661 |
151 | MP0005395_other_phenotype | 0.45289552 |
152 | MP0003075_altered_response_to | 0.44411492 |
153 | MP0002653_abnormal_ependyma_morphology | 0.43677477 |
154 | MP0002970_abnormal_white_adipose | 0.43254545 |
155 | MP0003453_abnormal_keratinocyte_physiol | 0.42644248 |
156 | MP0009384_cardiac_valve_regurgitation | 0.42038280 |
157 | MP0002837_dystrophic_cardiac_calcinosis | 0.41655163 |
158 | MP0003953_abnormal_hormone_level | 0.40504608 |
159 | MP0005187_abnormal_penis_morphology | 0.40234429 |
160 | MP0002822_catalepsy | 0.39095898 |
161 | MP0010352_gastrointestinal_tract_polyps | 0.37906193 |
162 | MP0006036_abnormal_mitochondrial_physio | 0.36928364 |
163 | MP0003283_abnormal_digestive_organ | 0.36221911 |
164 | MP0001881_abnormal_mammary_gland | 0.35509471 |
165 | MP0009780_abnormal_chondrocyte_physiolo | 0.35322020 |
166 | MP0000371_diluted_coat_color | 0.34430204 |
167 | MP0003632_abnormal_nervous_system | 0.33919198 |
168 | MP0000747_muscle_weakness | 0.33788696 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 6.77211357 |
2 | Intrahepatic cholestasis (HP:0001406) | 6.60841917 |
3 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.92944889 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.89026680 |
5 | Xanthomatosis (HP:0000991) | 5.83683840 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.31353657 |
7 | Complement deficiency (HP:0004431) | 4.99008256 |
8 | Hyperlipoproteinemia (HP:0010980) | 4.89125176 |
9 | Prolonged partial thromboplastin time (HP:0003645) | 4.81176596 |
10 | Abnormality of glycolipid metabolism (HP:0010969) | 4.26754547 |
11 | Abnormality of liposaccharide metabolism (HP:0010968) | 4.26754547 |
12 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 4.26754547 |
13 | Hypolipoproteinemia (HP:0010981) | 4.23982564 |
14 | Epidermoid cyst (HP:0200040) | 4.21393017 |
15 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.08785227 |
16 | Hyperammonemia (HP:0001987) | 4.03537218 |
17 | Hyperglycinemia (HP:0002154) | 4.03074432 |
18 | Hypoalphalipoproteinemia (HP:0003233) | 3.95842704 |
19 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.93217835 |
20 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.91199630 |
21 | Ketosis (HP:0001946) | 3.88477136 |
22 | Abnormality of the common coagulation pathway (HP:0010990) | 3.84181259 |
23 | Hyperglycinuria (HP:0003108) | 3.76306600 |
24 | Abnormality of glycine metabolism (HP:0010895) | 3.68644425 |
25 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.68644425 |
26 | Neurofibrillary tangles (HP:0002185) | 3.59113475 |
27 | Joint hemorrhage (HP:0005261) | 3.57309713 |
28 | Fat malabsorption (HP:0002630) | 3.55518516 |
29 | Abnormality of complement system (HP:0005339) | 3.54125657 |
30 | Hypercholesterolemia (HP:0003124) | 3.48923059 |
31 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.32920668 |
32 | Abnormality of methionine metabolism (HP:0010901) | 3.22127909 |
33 | Myocardial infarction (HP:0001658) | 3.21754167 |
34 | Premature rupture of membranes (HP:0001788) | 3.20972491 |
35 | Cerebral inclusion bodies (HP:0100314) | 3.19054099 |
36 | Hypoglycemic coma (HP:0001325) | 3.17037549 |
37 | Conjugated hyperbilirubinemia (HP:0002908) | 3.14373557 |
38 | Protrusio acetabuli (HP:0003179) | 3.12819714 |
39 | Hepatocellular carcinoma (HP:0001402) | 3.11717169 |
40 | Abnormality of the intrinsic pathway (HP:0010989) | 3.06676921 |
41 | Dysostosis multiplex (HP:0000943) | 3.06570877 |
42 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.99686264 |
43 | Skin nodule (HP:0200036) | 2.83773940 |
44 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.82543530 |
45 | Gout (HP:0001997) | 2.75799409 |
46 | Increased connective tissue (HP:0009025) | 2.75330526 |
47 | Spastic diplegia (HP:0001264) | 2.75127158 |
48 | Abnormality of nucleobase metabolism (HP:0010932) | 2.73776438 |
49 | Hyperbilirubinemia (HP:0002904) | 2.73081173 |
50 | Increased variability in muscle fiber diameter (HP:0003557) | 2.72849230 |
51 | Loss of speech (HP:0002371) | 2.72502856 |
52 | Ketoacidosis (HP:0001993) | 2.71959321 |
53 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.69440085 |
54 | Supranuclear gaze palsy (HP:0000605) | 2.68989573 |
55 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.67147201 |
56 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.67147201 |
57 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.67147201 |
58 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.67135950 |
59 | Abnormality of macrophages (HP:0004311) | 2.62804030 |
60 | Mitral stenosis (HP:0001718) | 2.61042698 |
61 | Abnormality of purine metabolism (HP:0004352) | 2.60821525 |
62 | Hypochromic microcytic anemia (HP:0004840) | 2.60346750 |
63 | Abnormality of the lower motor neuron (HP:0002366) | 2.60002597 |
64 | Vertebral compression fractures (HP:0002953) | 2.59501487 |
65 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.54734873 |
66 | Eczematoid dermatitis (HP:0000976) | 2.51641037 |
67 | Exercise-induced myalgia (HP:0003738) | 2.51517163 |
68 | Hand muscle atrophy (HP:0009130) | 2.47652215 |
69 | Distal upper limb amyotrophy (HP:0007149) | 2.47391287 |
70 | Upper limb amyotrophy (HP:0009129) | 2.47391287 |
71 | Vascular calcification (HP:0004934) | 2.44949476 |
72 | Steatorrhea (HP:0002570) | 2.43703947 |
73 | Mucopolysacchariduria (HP:0008155) | 2.42366875 |
74 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.42366875 |
75 | Spontaneous abortion (HP:0005268) | 2.40470280 |
76 | Abnormality of serum amino acid levels (HP:0003112) | 2.39932091 |
77 | Neuronal loss in central nervous system (HP:0002529) | 2.38765531 |
78 | Delayed CNS myelination (HP:0002188) | 2.37297281 |
79 | Hypercortisolism (HP:0001578) | 2.36292338 |
80 | Cerebral aneurysm (HP:0004944) | 2.35632685 |
81 | Systemic lupus erythematosus (HP:0002725) | 2.35378250 |
82 | Distal lower limb amyotrophy (HP:0008944) | 2.33869436 |
83 | Cholelithiasis (HP:0001081) | 2.33355653 |
84 | Cardiovascular calcification (HP:0011915) | 2.32439813 |
85 | Increased cerebral lipofuscin (HP:0011813) | 2.31966991 |
86 | Vacuolated lymphocytes (HP:0001922) | 2.31568950 |
87 | Hemorrhage of the eye (HP:0011885) | 2.30896332 |
88 | Turricephaly (HP:0000262) | 2.30473276 |
89 | Apathy (HP:0000741) | 2.30150119 |
90 | Hydroxyprolinuria (HP:0003080) | 2.29996135 |
91 | Abnormality of proline metabolism (HP:0010907) | 2.29996135 |
92 | Esophageal varix (HP:0002040) | 2.28680812 |
93 | Acanthocytosis (HP:0001927) | 2.27771161 |
94 | Malnutrition (HP:0004395) | 2.27156562 |
95 | Abnormal gallbladder morphology (HP:0012437) | 2.26467849 |
96 | Hypoplasia of the iris (HP:0007676) | 2.26210710 |
97 | Spinal rigidity (HP:0003306) | 2.25911639 |
98 | Neonatal onset (HP:0003623) | 2.23684118 |
99 | Abnormality of the Achilles tendon (HP:0005109) | 2.21686410 |
100 | Asymmetric septal hypertrophy (HP:0001670) | 2.20960237 |
101 | Interstitial pulmonary disease (HP:0006530) | 2.19604925 |
102 | Diminished motivation (HP:0000745) | 2.18938014 |
103 | Distal lower limb muscle weakness (HP:0009053) | 2.18650210 |
104 | Abnormal gallbladder physiology (HP:0012438) | 2.18591087 |
105 | Cholecystitis (HP:0001082) | 2.18591087 |
106 | Type 1 muscle fiber predominance (HP:0003803) | 2.18381199 |
107 | Sensorimotor neuropathy (HP:0007141) | 2.16095012 |
108 | Slender build (HP:0001533) | 2.15521383 |
109 | Abnormal cartilage morphology (HP:0002763) | 2.12854672 |
110 | Vascular tortuosity (HP:0004948) | 2.09632996 |
111 | Atrophic scars (HP:0001075) | 2.07961742 |
112 | Irritability (HP:0000737) | 2.07392925 |
113 | Global brain atrophy (HP:0002283) | 2.05723888 |
114 | Aneurysm (HP:0002617) | 2.04957109 |
115 | Cervical subluxation (HP:0003308) | 2.04210375 |
116 | Difficulty climbing stairs (HP:0003551) | 2.04034951 |
117 | Pseudobulbar signs (HP:0002200) | 2.03030797 |
118 | Genu recurvatum (HP:0002816) | 2.02763804 |
119 | Hypoglycemic seizures (HP:0002173) | 2.02659005 |
120 | Back pain (HP:0003418) | 2.02412231 |
121 | Metabolic acidosis (HP:0001942) | 2.01594412 |
122 | Reticulocytosis (HP:0001923) | 2.00790581 |
123 | Upper motor neuron abnormality (HP:0002127) | 1.99947553 |
124 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.99252848 |
125 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.98772752 |
126 | Prolonged neonatal jaundice (HP:0006579) | 1.98403647 |
127 | Hyperglycemia (HP:0003074) | 1.96474098 |
128 | Myositis (HP:0100614) | 1.94739166 |
129 | Short nail (HP:0001799) | 1.94229594 |
130 | Recurrent abscess formation (HP:0002722) | 1.93253162 |
131 | Recurrent bacterial skin infections (HP:0005406) | 1.91956985 |
132 | Wormian bones (HP:0002645) | 1.91753832 |
133 | Status epilepticus (HP:0002133) | 1.91511327 |
134 | Orchitis (HP:0100796) | 1.90935525 |
135 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89609609 |
136 | Ankle contracture (HP:0006466) | 1.88857635 |
137 | Stroke (HP:0001297) | 1.88779344 |
138 | Arterial tortuosity (HP:0005116) | 1.88168401 |
139 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.86989404 |
140 | Mutism (HP:0002300) | 1.86241538 |
141 | Dilatation of the ascending aorta (HP:0005111) | 1.85053103 |
142 | Late onset (HP:0003584) | 1.83905658 |
143 | Amyloidosis (HP:0011034) | 1.83299127 |
144 | Peripheral hypomyelination (HP:0007182) | 1.83157080 |
145 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.82568536 |
146 | Dicarboxylic aciduria (HP:0003215) | 1.82568536 |
147 | Poikilocytosis (HP:0004447) | 1.82553517 |
148 | Wrist flexion contracture (HP:0001239) | 1.80550813 |
149 | Glomerulonephritis (HP:0000099) | 1.79489797 |
150 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.78514127 |
151 | Spastic tetraparesis (HP:0001285) | 1.78490986 |
152 | Abnormality of the gallbladder (HP:0005264) | 1.78070982 |
153 | Albinism (HP:0001022) | 1.77977058 |
154 | Increased purine levels (HP:0004368) | 1.77535974 |
155 | Hyperuricemia (HP:0002149) | 1.77535974 |
156 | Tetraparesis (HP:0002273) | 1.76614317 |
157 | Myopathic facies (HP:0002058) | 1.76379353 |
158 | Polycythemia (HP:0001901) | 1.76052253 |
159 | Death in childhood (HP:0003819) | 1.75161372 |
160 | Aortic aneurysm (HP:0004942) | 1.75154546 |
161 | Hyporeflexia of lower limbs (HP:0002600) | 1.74159975 |
162 | Rapidly progressive (HP:0003678) | 1.74072981 |
163 | Lower limb amyotrophy (HP:0007210) | 1.73990992 |
164 | Nuclear cataract (HP:0100018) | 1.73138937 |
165 | Peritonitis (HP:0002586) | 1.72980539 |
166 | Gingival bleeding (HP:0000225) | 1.72936547 |
167 | Long palpebral fissure (HP:0000637) | 1.72410468 |
168 | Spontaneous hematomas (HP:0007420) | 1.72265279 |
169 | Spondylolisthesis (HP:0003302) | 1.71868650 |
170 | Overgrowth (HP:0001548) | 1.71300846 |
171 | J-shaped sella turcica (HP:0002680) | 1.70778074 |
172 | Tetraplegia (HP:0002445) | 1.69150077 |
173 | Decreased motor nerve conduction velocity (HP:0003431) | 1.68755658 |
174 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.67535195 |
175 | Abnormality of iron homeostasis (HP:0011031) | 1.67523751 |
176 | Obstructive sleep apnea (HP:0002870) | 1.66610283 |
177 | Muscle fiber splitting (HP:0003555) | 1.65515370 |
178 | Disinhibition (HP:0000734) | 1.63795489 |
179 | Muscle fibrillation (HP:0010546) | 1.63695458 |
180 | Nephritis (HP:0000123) | 1.63338709 |
181 | Difficulty running (HP:0009046) | 1.61908606 |
182 | Deformed sella turcica (HP:0002681) | 1.61672655 |
183 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.60864159 |
184 | Thin bony cortex (HP:0002753) | 1.60191768 |
185 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.60090911 |
186 | Gingivitis (HP:0000230) | 1.58155201 |
187 | Achilles tendon contracture (HP:0001771) | 1.57777781 |
188 | Aortic dissection (HP:0002647) | 1.57381844 |
189 | Ankle clonus (HP:0011448) | 1.56389552 |
190 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.56107778 |
191 | Bilateral sensorineural hearing impairment (HP:0008619) | 1.55928861 |
192 | Neoplasm of the heart (HP:0100544) | 1.54587659 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TRIB3 | 3.89578867 |
2 | SIK1 | 3.84690129 |
3 | ERN1 | 3.34905471 |
4 | BCKDK | 3.15242607 |
5 | FGFR4 | 3.07944756 |
6 | PKN2 | 2.82013610 |
7 | PRPF4B | 2.63710427 |
8 | ICK | 2.36277400 |
9 | MAP2K3 | 2.15939353 |
10 | FLT3 | 2.02651467 |
11 | MAP3K10 | 2.00666766 |
12 | LATS1 | 1.95885836 |
13 | MAP3K6 | 1.92116621 |
14 | PTK6 | 1.91898196 |
15 | PDGFRA | 1.77579839 |
16 | TESK1 | 1.76993453 |
17 | CDK12 | 1.72102866 |
18 | MAP3K3 | 1.70898493 |
19 | MARK2 | 1.69603881 |
20 | RIPK1 | 1.66542592 |
21 | PDK4 | 1.60002397 |
22 | PDK3 | 1.60002397 |
23 | ERBB4 | 1.53211718 |
24 | EPHB2 | 1.49963388 |
25 | EPHB1 | 1.48371935 |
26 | IRAK3 | 1.46719135 |
27 | TYRO3 | 1.45286043 |
28 | CAMK1D | 1.44034241 |
29 | PRKD2 | 1.40021984 |
30 | MAP3K11 | 1.39254277 |
31 | MET | 1.35261655 |
32 | TESK2 | 1.31909853 |
33 | KSR2 | 1.29617845 |
34 | EEF2K | 1.29038473 |
35 | TAOK3 | 1.28816717 |
36 | SIK3 | 1.26869712 |
37 | ZAP70 | 1.25714208 |
38 | MTOR | 1.25084415 |
39 | DAPK2 | 1.24120158 |
40 | SGK3 | 1.22530632 |
41 | CSK | 1.22466302 |
42 | MAP2K7 | 1.21342820 |
43 | MAPK11 | 1.18683268 |
44 | BLK | 1.18479451 |
45 | MAP3K7 | 1.16144364 |
46 | FGFR2 | 1.15460280 |
47 | TGFBR2 | 1.14871015 |
48 | DYRK1B | 1.13537409 |
49 | TTN | 1.12051701 |
50 | FGR | 1.10859808 |
51 | PTK2 | 1.10673791 |
52 | INSRR | 1.10361527 |
53 | MAP2K4 | 1.10094672 |
54 | CDC42BPA | 1.07682376 |
55 | CAMK1G | 1.06900830 |
56 | MAP3K14 | 1.06801088 |
57 | MST1R | 1.06712128 |
58 | MAP3K4 | 1.06712026 |
59 | RET | 1.06425710 |
60 | MARK1 | 1.06101969 |
61 | LATS2 | 1.06012583 |
62 | NTRK1 | 1.05049806 |
63 | STK38 | 1.00960423 |
64 | PRKD3 | 1.00954985 |
65 | NEK1 | 1.00419796 |
66 | BMX | 0.99467535 |
67 | MAP3K9 | 0.99380120 |
68 | PDK2 | 0.97252589 |
69 | TYK2 | 0.96258465 |
70 | MAP4K1 | 0.96175446 |
71 | EPHA2 | 0.93989538 |
72 | JAK2 | 0.90778975 |
73 | RPS6KA2 | 0.89686434 |
74 | MAP3K5 | 0.89483491 |
75 | PDPK1 | 0.89291694 |
76 | CDK6 | 0.89231214 |
77 | PINK1 | 0.89212982 |
78 | PRKAA1 | 0.88836168 |
79 | JAK1 | 0.88783154 |
80 | NEK9 | 0.87282484 |
81 | DDR2 | 0.87037682 |
82 | MATK | 0.85394348 |
83 | IRAK2 | 0.81914773 |
84 | MAP3K1 | 0.81859024 |
85 | MOS | 0.80010762 |
86 | ERBB2 | 0.79835385 |
87 | GRK7 | 0.78681067 |
88 | LIMK1 | 0.78107054 |
89 | STK3 | 0.78057383 |
90 | PDK1 | 0.77573264 |
91 | PAK6 | 0.76232342 |
92 | JAK3 | 0.74985427 |
93 | IRAK4 | 0.74797093 |
94 | PRKAA2 | 0.74615734 |
95 | CAMKK1 | 0.71081032 |
96 | CSF1R | 0.69483797 |
97 | FES | 0.69156129 |
98 | PRKCZ | 0.68458643 |
99 | MAPK7 | 0.67410536 |
100 | PIM2 | 0.67165324 |
101 | TRIM28 | 0.66350105 |
102 | TAOK1 | 0.63918195 |
103 | HCK | 0.63869841 |
104 | GRK6 | 0.63006481 |
105 | KSR1 | 0.61784533 |
106 | FGFR3 | 0.61430634 |
107 | PDGFRB | 0.60968600 |
108 | IKBKE | 0.60311970 |
109 | MARK3 | 0.59592323 |
110 | EPHA3 | 0.58851213 |
111 | RIPK4 | 0.58647001 |
112 | PAK3 | 0.58107355 |
113 | PIK3CG | 0.56680083 |
114 | PRKD1 | 0.56520729 |
115 | PHKG2 | 0.55255221 |
116 | PHKG1 | 0.55255221 |
117 | MAP3K2 | 0.54842417 |
118 | LMTK2 | 0.54338910 |
119 | DYRK3 | 0.53373280 |
120 | PRKCH | 0.52439498 |
121 | SGK494 | 0.51717755 |
122 | SGK223 | 0.51717755 |
123 | PAK4 | 0.51443338 |
124 | GSK3A | 0.50609795 |
125 | TAOK2 | 0.50489494 |
126 | SGK2 | 0.50345012 |
127 | LRRK2 | 0.49816708 |
128 | TNK2 | 0.49633865 |
129 | AKT3 | 0.49073759 |
130 | RPS6KC1 | 0.48690630 |
131 | RPS6KL1 | 0.48690630 |
132 | MAPK4 | 0.48313861 |
133 | ALK | 0.47598350 |
134 | FYN | 0.46483119 |
135 | PRKACG | 0.43308520 |
136 | PAK2 | 0.42468212 |
137 | MAP2K1 | 0.41983720 |
138 | MAP3K8 | 0.41858040 |
139 | ABL2 | 0.41517980 |
140 | SIK2 | 0.40850754 |
141 | TBK1 | 0.40362064 |
142 | MAPK12 | 0.39574991 |
143 | NEK2 | 0.38991049 |
144 | SCYL2 | 0.38229268 |
145 | MELK | 0.35379976 |
146 | PTK2B | 0.35149841 |
147 | CAMK4 | 0.34950352 |
148 | FGFR1 | 0.34036109 |
149 | FRK | 0.32437180 |
150 | STK38L | 0.31918769 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.22911568 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 4.12415603 |
3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.49917141 |
4 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.08732190 |
5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 3.07903050 |
6 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.55888372 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.54500114 |
8 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.52624026 |
9 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.49534029 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.49208450 |
11 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.31816603 |
12 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.23543012 |
13 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.06689704 |
14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.02531319 |
15 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.95273246 |
16 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.93088509 |
17 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.86704125 |
18 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.84686913 |
19 | Peroxisome_Homo sapiens_hsa04146 | 1.79145210 |
20 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.77486079 |
21 | Other glycan degradation_Homo sapiens_hsa00511 | 1.77091180 |
22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.74507502 |
23 | Bile secretion_Homo sapiens_hsa04976 | 1.74284608 |
24 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.72275811 |
25 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.64207108 |
26 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.59451158 |
27 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.58962359 |
28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.57507495 |
29 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.56938174 |
30 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.52784910 |
31 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.52343960 |
32 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.51258204 |
33 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.49630661 |
34 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.47760123 |
35 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.47375524 |
36 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.46941347 |
37 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.44865176 |
38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.44422267 |
39 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.41826586 |
40 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.40204759 |
41 | Malaria_Homo sapiens_hsa05144 | 1.39270586 |
42 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.37823053 |
43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.31189757 |
44 | Retinol metabolism_Homo sapiens_hsa00830 | 1.30722163 |
45 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.30352602 |
46 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.28381914 |
47 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.27674495 |
48 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.27515055 |
49 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.27211838 |
50 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.26852166 |
51 | Salmonella infection_Homo sapiens_hsa05132 | 1.26183435 |
52 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.25674666 |
53 | ABC transporters_Homo sapiens_hsa02010 | 1.23124911 |
54 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.22900855 |
55 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.22549427 |
56 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.22374084 |
57 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.20532781 |
58 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.20483201 |
59 | Shigellosis_Homo sapiens_hsa05131 | 1.19260434 |
60 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 1.18867842 |
61 | Tuberculosis_Homo sapiens_hsa05152 | 1.18428381 |
62 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.18277887 |
63 | Lysine degradation_Homo sapiens_hsa00310 | 1.18197548 |
64 | Phagosome_Homo sapiens_hsa04145 | 1.16714090 |
65 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.16419197 |
66 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16326750 |
67 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14240842 |
68 | Hepatitis C_Homo sapiens_hsa05160 | 1.12673401 |
69 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.11590795 |
70 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.11373331 |
71 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 1.10218390 |
72 | Endocytosis_Homo sapiens_hsa04144 | 1.09959648 |
73 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.08490285 |
74 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 1.08404633 |
75 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.08362573 |
76 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.06305038 |
77 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05720146 |
78 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.05069677 |
79 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.04238920 |
80 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.03194416 |
81 | Regulation of autophagy_Homo sapiens_hsa04140 | 1.02589222 |
82 | Focal adhesion_Homo sapiens_hsa04510 | 1.01063433 |
83 | Pertussis_Homo sapiens_hsa05133 | 1.01001203 |
84 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.00752206 |
85 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.00750438 |
86 | Endometrial cancer_Homo sapiens_hsa05213 | 0.99681453 |
87 | Leishmaniasis_Homo sapiens_hsa05140 | 0.95613455 |
88 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.94732006 |
89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.93993087 |
90 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.93930786 |
91 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91949539 |
92 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.91506761 |
93 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.90484155 |
94 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90396679 |
95 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89124254 |
96 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.88206223 |
97 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.87896843 |
98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.87865798 |
99 | Glioma_Homo sapiens_hsa05214 | 0.85658715 |
100 | Hepatitis B_Homo sapiens_hsa05161 | 0.84291578 |
101 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.83832443 |
102 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.83474774 |
103 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.82088313 |
104 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.80260033 |
105 | Influenza A_Homo sapiens_hsa05164 | 0.79919575 |
106 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.79005761 |
107 | Apoptosis_Homo sapiens_hsa04210 | 0.78995703 |
108 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.78708350 |
109 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.77393219 |
110 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.77019106 |
111 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.77013019 |
112 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.76912800 |
113 | Sulfur relay system_Homo sapiens_hsa04122 | 0.76017069 |
114 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.75893608 |
115 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.74882110 |
116 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.72812444 |
117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.72398972 |
118 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.71334556 |
119 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.69089078 |
120 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.67770523 |
121 | Platelet activation_Homo sapiens_hsa04611 | 0.67003814 |
122 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.66881556 |
123 | Axon guidance_Homo sapiens_hsa04360 | 0.66440530 |
124 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.65931695 |
125 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65539021 |
126 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.65308815 |
127 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.65167793 |
128 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.64736708 |
129 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.64666381 |
130 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.64253656 |
131 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.63889778 |
132 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.62192225 |
133 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62008091 |
134 | Insulin resistance_Homo sapiens_hsa04931 | 0.61560551 |
135 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.60927552 |
136 | Legionellosis_Homo sapiens_hsa05134 | 0.60160648 |
137 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.58796518 |
138 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58163504 |
139 | Gap junction_Homo sapiens_hsa04540 | 0.55817537 |
140 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.55453018 |
141 | Prion diseases_Homo sapiens_hsa05020 | 0.55341669 |
142 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54563113 |
143 | Measles_Homo sapiens_hsa05162 | 0.53269140 |
144 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.52985524 |
145 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.51891997 |
146 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.50239792 |
147 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.49985037 |
148 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.47701567 |
149 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.46760968 |
150 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.45129710 |
151 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.43940601 |
152 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41476659 |
153 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.39369272 |
154 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.36297891 |
155 | Galactose metabolism_Homo sapiens_hsa00052 | 0.34718321 |
156 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.26250703 |
157 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.23281434 |
158 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.21617920 |
159 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.21013747 |
160 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.20899025 |
161 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.19721580 |
162 | Metabolic pathways_Homo sapiens_hsa01100 | 0.19098046 |
163 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.17972331 |
164 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.16095981 |
165 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.14801388 |
166 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.13389042 |
167 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.08219235 |
168 | Amoebiasis_Homo sapiens_hsa05146 | 0.07594857 |
169 | Bladder cancer_Homo sapiens_hsa05219 | 0.06641979 |
170 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.05295438 |
171 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.02771035 |
172 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.00121246 |
173 | FoxO signaling pathway_Homo sapiens_hsa04068 | -0.0669018 |
174 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | -0.0394707 |
175 | Protein digestion and absorption_Homo sapiens_hsa04974 | -0.0289572 |
176 | Renin-angiotensin system_Homo sapiens_hsa04614 | -0.0279606 |
177 | Non-small cell lung cancer_Homo sapiens_hsa05223 | -0.0249768 |
178 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | -0.0208409 |
179 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | -0.0132764 |
180 | Lysosome_Homo sapiens_hsa04142 | -0.0033113 |